124 related articles for article (PubMed ID: 85607)
21. Some aspects of the radiopharmaceutics of 99m-Tc-phytate.
Sewatkar AB; Noronha OP; Ganatra RD; Glenn HJ
Nucl Med (Stuttg); 1975 Mar; 14(1):46-51. PubMed ID: 1144054
[TBL] [Abstract][Full Text] [Related]
22. [Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (1) 99mTc-pertechnetate, 99mTc-human serum albumin, and 99mTc-trasylol].
Ito K; Kobayashi S; Hisada K; Ando A; Tonami N
Radioisotopes; 1976 Oct; 25(10):614-21. PubMed ID: 1088303
[TBL] [Abstract][Full Text] [Related]
23. Tumor imaging with 99mTc-labelled antibody fragments.
Rhodes BA
Radioisotopes; 1984 Apr; 33(4):230-6. PubMed ID: 6382454
[No Abstract] [Full Text] [Related]
24. The reaction of stannous ion with thiomalic acid in the preparation of 99mTc--thiomalate as a radiopharmaceutical.
Ikeda I; Sakaguchi T
Int J Appl Radiat Isot; 1977 Apr; 28(4):387-93. PubMed ID: 863534
[No Abstract] [Full Text] [Related]
25. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
Rembelska MJ; Liniecki J
Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
[TBL] [Abstract][Full Text] [Related]
26. Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex: implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn (II) reduction of pertechnetate.
Deutsch E; Elder RC; Lange BA; Vaal MJ; Lay DG
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4287-9. PubMed ID: 1069984
[TBL] [Abstract][Full Text] [Related]
27. Small peptides radiolabeled with 99mTc.
Lister-James J; Moyer BR; Dean T
Q J Nucl Med; 1996 Sep; 40(3):221-33. PubMed ID: 8961801
[TBL] [Abstract][Full Text] [Related]
28. Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.
Kumar S; Kumar Mishra A; Chhikara BS; Chuttani K; Kumar Sharma R
Hell J Nucl Med; 2008; 11(2):91-5. PubMed ID: 18815662
[TBL] [Abstract][Full Text] [Related]
29. [Study on tumor affinity of 99mTc-labeled radiopharmaceuticals--the comprehensive investigation of various 99mTc-labeled radiopharmaceuticals for tumor affinity in contrast to biologic behavior of 67Ga-citrate-- (author's transl)].
Itoh K; Kobayashi S; Hisada K; Tonami N; Ando A
Radioisotopes; 1977 May; 26(5):296-301. PubMed ID: 578941
[No Abstract] [Full Text] [Related]
30. Studies on the chemical reactivity of copper bleomycin.
Antholine WE; Solaiman D; Saryan LA; Petering DH
J Inorg Biochem; 1982 Oct; 17(2):75-94. PubMed ID: 6184448
[TBL] [Abstract][Full Text] [Related]
31. [99mTc-ethylenediamine-N, N-diacetic acid; a radiopharmaceutical with tumor affinity].
Imoto T
Fukuoka Igaku Zasshi; 1984 May; 75(5):221-40. PubMed ID: 6436155
[No Abstract] [Full Text] [Related]
32. [Tumor affinity of 99mTc-labeled radiopharmaceuticals, 99mTc-Sn-urokinase and 99mTc-Sn-mannitol].
Ito K; Kobayashi S; Hisada K; Tonami N; Ando A
Radioisotopes; 1977 Jan; 26(1):6-12. PubMed ID: 577026
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
[TBL] [Abstract][Full Text] [Related]
34. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
Liniecki J; Rembelska M; Koniarek B
Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycin.
Stern PH; Helpern SE; Hagan PL; Howell SB; Dabbs JE; Gordon RM
J Natl Cancer Inst; 1981 May; 66(5):807-11. PubMed ID: 6164811
[TBL] [Abstract][Full Text] [Related]
36. Effect of the nature of technetium coordination complex on cell membrane permeability: mononuclear complex of 99mTc--penicillamine ethyl ester.
Horiuchi K; Yokoyama A; Tsuiki K; Tanaka H; Saji H
Int J Appl Radiat Isot; 1981 Aug; 32(8):545-51. PubMed ID: 7298232
[No Abstract] [Full Text] [Related]
37. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
Fritzberg AR; Lyster DM; Dolphin DH
J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of (99m)Tc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors.
Kumar P; Singh B; Ghai A; Chuttani K; Dhawan D; Mittal BR; Mishra AK
Appl Radiat Isot; 2015 May; 99():41-5. PubMed ID: 25702887
[TBL] [Abstract][Full Text] [Related]
39. [Current topics in radiopharmaceuticals in Japan. (IV). Quality control of "Kit" made radiopharmaceuticals--radiochemical purity of 99mTc radiopharmaceuticals].
Yokoyama A
Radioisotopes; 1984 Mar; 33(3):170-9. PubMed ID: 6382453
[No Abstract] [Full Text] [Related]
40. On the nature of technetium compounds. 1. A semiquantitative biological model system to assay 99mTc-complexes/radiopharmaceuticals.
Noronha OP; Venkateswarlu KS
Eur J Nucl Med; 1981 Mar; 6(3):121-9. PubMed ID: 7215375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
